The Blue Sky Proof-of-Concept (PoC) Fund will accelerate bold, neurotech breakthroughs nationwide, paving the way for a new generation of neurotechnologies to treat conditions such as depression, dementia, chronic pain, epilepsy, and nervous system injuries. The fund will support six-month hypothesis-testing projects with the potential to reshape a future where neurological conditions no longer limit human potential.
This initiative is part of the Cambridge NeuroWorks Programme, supported by multi-million-pound funding from the UK government’s Advanced Research and Invention Agency (ARIA). The initiative aims to identify and support innovators across the UK developing new treatments, devices, and diagnostic tools for neurological conditions.
